Cilostazol Tablet
Product Images NDC 63629-8796

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 63629-8796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Cilostazol (Image 1)

Chemical structure of Cilostazol displayed as a molecular diagram showing its connected atoms and ring structures.*

FDA Label Image

Figure1 (Image 2)

A line graph showing plasma concentrations (ng/mL) of Cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol over a 24-hour period. The graph plots time (hours) on the x-axis and plasma concentration on the y-axis, illustrating the pharmacokinetic profiles of the drug and metabolites.*

FDA Label Image

Figure 2 (Image 3)

Bar chart depicting percent mean improvement in maximal walking distance across multiple clinical trials for Cilostazol 50 mg b.i.d., Cilostazol 100 mg b.i.d., and placebo groups. The trials vary in sample size and duration, with Cilostazol 100 mg b.i.d. consistently showing higher improvement percentages compared to placebo and Cilostazol 50 mg b.i.d. in most trials presented.*

FDA Label Image

Label (Lbl636298796)

Label for Cilostazol Tablets USP 50 mg oral tablets by Bryant Ranch Prepack. The label displays NDC 63629-8796-1, a barcode, and indicates the package contains 60 tablets. Storage instructions and a dosage note are present. The BRP Pharmaceuticals logo appears at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.